5-(5-chlorothiophen-2-yl)-N-[(1,5-dimethylpyrazol-4-yl)methyl]-N-methyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxamide

5-(5-chlorothiophen-2-yl)-N-[(1,5-dimethylpyrazol-4-yl)methyl]-N-methyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxamide Struktur
522597-04-2
CAS-Nr.
522597-04-2
Englisch Name:
5-(5-chlorothiophen-2-yl)-N-[(1,5-dimethylpyrazol-4-yl)methyl]-N-methyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxamide
Synonyma:
5-(5-chlorothiophen-2-yl)-N-[(1,5-dimethylpyrazol-4-yl)methyl]-N-methyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxamide;Pyrazolo[1,5-a]pyrimidine-2-carboxamide, 5-(5-chloro-2-thienyl)-N-[(1,5-dimethyl-1H-pyrazol-4-yl)methyl]-N-methyl-7-(trifluoromethyl)-
CBNumber:
CB94415416
Summenformel:
C19H16ClF3N6OS
Molgewicht:
468.88
MOL-Datei:
522597-04-2.mol

5-(5-chlorothiophen-2-yl)-N-[(1,5-dimethylpyrazol-4-yl)methyl]-N-methyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxamide Eigenschaften

Sicherheit

5-(5-chlorothiophen-2-yl)-N-[(1,5-dimethylpyrazol-4-yl)methyl]-N-methyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxamide Chemische Eigenschaften,Einsatz,Produktion Methoden

5-(5-chlorothiophen-2-yl)-N-[(1,5-dimethylpyrazol-4-yl)methyl]-N-methyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxamide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


5-(5-chlorothiophen-2-yl)-N-[(1,5-dimethylpyrazol-4-yl)methyl]-N-methyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxamide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Alinda Chemical Ltd. +7 (495) 672-17-08
sale@alinda.ru Russia 68136 55

  • 5-(5-chlorothiophen-2-yl)-N-[(1,5-dimethylpyrazol-4-yl)methyl]-N-methyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxamide
  • Pyrazolo[1,5-a]pyrimidine-2-carboxamide, 5-(5-chloro-2-thienyl)-N-[(1,5-dimethyl-1H-pyrazol-4-yl)methyl]-N-methyl-7-(trifluoromethyl)-
  • 522597-04-2
Copyright 2019 © ChemicalBook. All rights reserved